The application of permanent middle cerebral artery ligation in the mouse

Journal of Visualized Experiments

Volumn , Issue 53, 2011, Pages

  Colak, Gozde ^a   Filiano, Anthony J ^b   Johnson, Gail V W ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

^b The University of Alabama at Birmingham   (United States)

Author keywords

Brain; Issue 53; Medicine; Middle cerebral artery ligation; Mouse; Stroke

Indexed keywords

EID: 80355132687     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/3039     Document Type: Article

References (23)

1. Britton, M., Rafols, J., Alousi, S., & Dunbar, J.C. The effects of middle cerebral artery occlusion on central nervous system apoptotic events in normal and diabetic rats. Int J Exp Diabesity Res. 4, 13-20 (2003).
2. Ciceri, P., Rabuffetti, M., Monopoli, A., & Nicosia, S. Production of leukotrienes in a model of focal cerebral ischaemia in the rat. Br J Pharmacol. 133, 1323-1329 (2001).
3. Jin, K., et al. Delayed transplantation of human neural precursor cells improves outcome from focal cerebral ischemia in aged rats. Aging Cell. 9, 1076-1083 (2010).
4. McCaig, D., et al. Evolution of GADD34 expression after focal cerebral ischaemia. Brain Res. 1034, 51-61 (2005).
5. Shirotani, T., Shima, K., & Chigasaki, H. In vivo studies of extracellular metabolites in the striatum after distal middle cerebral artery occlusion in stroke-prone spontaneously hypertensive rats. Stroke. 26, 878-884 (1995).
6. Wu, Y.P., Tan, C.K., & Ling, E.A. Expression of Fos-like immunoreactivity in the brain and spinal cord of rats following middle cerebral artery occlusion. Exp Brain Res. 115, 129-136 (1997).
7. Tamura, A., Graham, D.I., McCulloch, J. & Teasdale, G.M. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab. 1, 53-60 (1981).
8. Bederson, J.B., et al. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 17, 472-476 (1986).
9. Carswell, H.V., et al. Genetic and gender influences on sensitivity to focal cerebral ischemia in the stroke-prone spontaneously hypertensive rat. Hypertension. 33, 681-685 (1999).
10. Mary, V., Wahl, F., Uzan, A. & Stutzmann, J.M. Enoxaparin in experimental stroke: neuroprotection and therapeutic window of opportunity. Stroke. 32, 993-999 (2001).
11. Menzies, S.A., Hoff, J.T., & Betz, A.L. Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery. 31, 100-106; discussion 106-107 (1992).
12. Iaci, J.F., et al. Glial growth factor 2 promotes functional recovery with treatment initiated up to 7 days after permanent focal ischemic stroke. Neuropharmacology. 59, 640-649 (2010).
13. Richard M. J. P., C.B.J., Khan B.V., Saleh T. M. Cellular mechanisms by which lipoic acid confers protection during the early stages of cerebral ischemia: A possible role for calcium. Neuroscience Research. doi:10.1016/j.neures.2010.12.011 (2011).
14. Heiss, W.D., et al. Progressive derangement of periinfarct viable tissue in ischemic stroke. J Cereb Blood Flow Metab. 12, 193-203 (1992).
15. Nedergaard, M., Gjedde, A., & Diemer, N.H. Focal ischemia of the rat brain: autoradiographic determination of cerebral glucose utilization, glucose content, and blood flow. J Cereb Blood Flow Metab. 6, 414-424 (1986).
16. Nowicki, J.P., Assumel-Lurdin, C., Duverger, D. & MacKenzie, E.T. Temporal evolution of regional energy metabolism following focal cerebral ischemia in the rat. J Cereb Blood Flow Metab. 8, 462-473 (1988).
17. Butcher, S.P., Bullock, R., Graham, D.I., & McCulloch, J. Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion. Stroke. 21, 1727-1733 (1990).
18. Arlicot, N., et al. Detection and quantification of remote microglial activation in rodent models of focal ischaemia using the TSPO radioligand CLINDE. Eur J Nucl Med Mol Imaging. 37, 2371-2380 (2010).
19. Moyanova, S.G., et al. Protective role for type 4 metabotropic glutamate receptors against ischemic brain damage. J Cereb Blood Flow Metab. (2010).
20. Ortolano, F., et al. Advances in imaging of new targets for pharmacological intervention in stroke: real-time tracking of T-cells in the ischaemic brain. Br J Pharmacol. 159, 808-811 (2010).
21. O'Neill M. J., C.J.A. Rodent models of focal cerebral ischemia. Current Protocols in Neuroscience. 9.6.1-9.6.32 (2000).
22. Lin, T.N., He, Y.Y., Wu, G., Khan, M., & Hsu, C.Y. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke. 24, 117-121 (1993).
23. Filiano, A.J., Tucholski, J., Dolan, P.J., Colak, G., & Johnson, G.V. Transglutaminase 2 protects against ischemic stroke. Neurobiol Dis. 39(3), 334-43 (2010).